Research and Development

Showing 15 posts of 9573 posts found.

opdivo

UK lung cancer patients get early access to breakthrough BMS drug

February 5, 2016 Research and Development, Sales and Marketing Bristol-Myers Squibb, MHRA, NICE, eams, opdivo

UK lung cancer patients are to get access to Bristol Myers-Squibb’s Opdivo (nivolumab) through the Early Access to Medicines Scheme …
la76169logo

Human Longevity makes three oncology appointments

February 4, 2016 Research and Development human longevity

Human Longevity, the genomics-based, technology company, has appointed ‘several key people’ for its oncology genomics program.Dr Kenneth Bloom will join …
World Cancer Day 2016

Cancer – dealing with the greatest health challenge of our time

February 4, 2016 Manufacturing and Production, Research and Development Cancer, IFPMA, R&D, World Cancer Day, collaboration, partnership

Cancer is one of the greatest health challenges of our time, and a leading cause of death in every corner …
Spending graph

Emerging markets top global R&D spending league

February 4, 2016 Research and Development GDP, OECD, R&D spending, investment

Data from the Organisation for Economic Co-operation and Development (OECD) shows Korea and Israel are investing much more in research …
ICR Sutton

London launches new cancer drug development hub

February 3, 2016 Research and Development

Research charities, hospitals, and London boroughs have combined to launch a new global hub for cancer research and treatment in …
Adaptimmune

GSK and Adaptimmune expand R&D collaboration

February 3, 2016 Research and Development Adaptimmune, GSK, T-cell therapy, immunotherapy, liposarcoma, rare cancer, sarcoma

Adaptimmune Therapeutics and GlaxoSmithKline have expanded the terms of their strategic collaboration agreement, to run clinical trials of Adaptimmune’s potential …
Daiichi Sankyo researchers

Daiichi Sankyo to expand access to clinical trial data

February 3, 2016 Research and Development Daiichi Sankyo, R&D, clinical trials, open access, open data, transparency

Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …
Brandicourt

Sanofi plans R&D jobs cuts in France

February 3, 2016 Manufacturing and Production, Research and Development Sanofi, Teva, cuts, job losses, olivier brandicourt, redundancies

Sanofi chief executive Olivier Brandicourt is reported to be planning hundreds of job cuts across the firm’s base in France, …

Pfizer revenues down, but above expectations

February 3, 2016 Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …
dr_barbara_fleck_-_head_of_ip-web

Crescendo Biologics appoints Dr Barbara Fleck as head of intellectual property

February 2, 2016 Research and Development Crescendo Biologics

Drug discovery and developer Crescendo Biologics has appointed Dr Barbara Fleck as head of intellectual property. Barbara Fleck, a European and …

Porton Biopharma expands cancer drug manufacturing capacity

February 2, 2016 Manufacturing and Production, Research and Development Erwinase

UK Life Sciences Minister George Freeman yesterday opened a new multi-million pound pharmaceutical manufacturing facility at Wiltshire-based Porton Biopharma Limited …
sun_pharma_logo

Sun Pharma takes on Novartis in the US with generic Glivec

February 2, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma

Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …
sanofi

Sanofi Pasteur launches Zika vaccine R&D

February 2, 2016 Manufacturing and Production, Research and Development Sanofi Pasteur, Vaccine, Zika virus

Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, says it has launched a vaccine research and development project …
bms_logo_square

Europe approves BMS hep C drug for HIV and liver transplant patients

February 1, 2016 Research and Development, Sales and Marketing Bristol-Myers Squibb, daclatasvir, daklinza

The European Commission has approved the expanded use of Bristol Myers-Squibb’s hepatitis C drug Daklinza (daclatasvir), to include liver transplant …
merck_innovation_centre

Merck launches health tech start-up program in Africa

February 1, 2016 Manufacturing and Production, Medical Communications, Research and Development

Merck has begun its equity-free accelerator program for digital health start-ups in Nairobi, Kenya- a three-month venture offering $15,000 equity-free …
The Gateway to Local Adoption Series

Latest content